Will InVivo Therapeutics Holdings Corp. (OTCBB:NVIV) Drop Below $1

The recent news around InVivo Therapeutics Holdings Corp. (OTCBB:NVIV) are crashing the stock hard. The ticker has lost more than 60% of its value in just over a week of trading and shows no tendency of returning to its previous value.

A lot of people are shedding their holdings after the change in management and the correction made to the expected period for FDA approval, after the FDA changed its standards for the testing. These changes extended the period for approval by 4-5 years, which seems to be a lot for investors that were holding in for the long run.

Everyone is trying to get out with a low loss and the volumes of traded stock that we see in the past 6 trade sessions are 10 times the ticker’s average. Yesterday’s session didn’t go unexpected as NVIV lost a further 14% in value.

The day didn’t start with the heavy trading that was expected from a falling stock and the ticker started sliding slowly in a downward direction until after noon. It seems that people got nervous from the fact that even if there was no big dumping the stock was still going down.

That showed right before 01:00 PM when the trades intensified. The whole day went in a similar way and the price at market close came at $1.47 per share. The volume, as mentioned before, was high with 2.4 million shares that had switched hands in the end of the day, generating a total trade value of $3.6 million.

Overall the situation at the moment is not rosy and to be honest there are no facts supporting a comeback in the near future. This is why we would advise you to do a lot of due diligence if you have any ideas of buying in the low and weigh out the risks, because if things turn sour the current price could turn out to be a high.

Affymax, Inc. (OTCMKTS:AFFY) are also having a hard time with the “review war” that was sparked by several articles on Seeking Alpha with different opinions. For now the stock’s movement is coordinated by this opposition and the stock can go anywhere until we hear some definitive news from the company itself.

Nuvilex, Inc. (OTCMKTS:NVLX) on the other hand is attracting interest from people interested in speculative stocks. This is due to its low price and inconsistent movement.